Maxitrol: Clinical Trials

4 trials of Maxitrol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown, 1 withdrawn. 2 Phase 1, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1
Not applicable1Completed 1
Phase 31Unknown 1

Follow Maxitrol: new trials by email Literature Review of Maxitrol trials Research Report on Maxitrol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Ocular Outcomes: A Dual-armed Study for Periorbital Burn Management
Steroid/Antibiotic (Maxitrol), 5-FU/Kenalog - Periorbital Burns
Phase 1WithdrawnVirginia Commonwealth University2026-06-052026-06-09
Intravitreal Carboplatin for the Treatment of Participants With Recurrent or Refractory Intraocular Retinoblastoma
Carboplatin, Maxitrol®, Focal Therapy - Retinoblastoma
Phase 1CompletedSt. Jude Children's Research Hospital82016-11-012020-02-20
Effect of Systemic Oxygen on Corneal Epithelial Wound Healing in Diabetic Patients Undergoing Pars Plana Vitrectomy
Dexamethasone 0.1%, Neomycin Sulfate and Polymyxin B Sulfate topical eye drops four times daily, Homatropine 2% eye drops thrice daily, Oxygen gas - Corneal Diseases
Not applicableCompletedUniversiti Sains Malaysia322013-10-012015-01-26
Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
MAXINOM®, Maxitrol® - Bacterial Conjunctivitis, Acute
Phase 3UnknownAzidus Brasil702011-02-012010-10-25

Conditions studied

Conjunctivitis, Bacterial (1)  ·  Corneal Diseases (1)  ·  Diabetes Mellitus (1)  ·  Retinoblastoma (1)

Sponsors

Azidus Brasil (1)  ·  St. Jude Children's Research Hospital (1)  ·  Universiti Sains Malaysia (1)  ·  Virginia Commonwealth University (1)

Countries

Brazil (1)  ·  United States (1)

Top investigators

Nikisha Richards, MD, FACS (1)  ·  Rachel Brennan, MD (1)  ·  Wee-Min Teh, MD (1)